Table 2

Patient characteristics and comorbidities by mortality

VariableAll patientsPositive patients
Alive
N=364
Deceased
N=69
Alive
N=38
Deceased
N=14
Age (years)61.3 (23.5)77.5 (13.2)63.6 (19.5)76.2 (14.0)
Sex, % male (N)48.4 (176)59.4 (41)60.5 (23)64.3 (9)
Ever smoker, % (N)3.1 (11)23.5 (16)0 (0)46.2 (6)
Comorbidities
Diabetes, % (N)
 Type 10.6 (2)2.9 (2)2.6 (1)0 (0)
 Type 20.8 (3)19.1 (13)0 (0)23.1 (3)
Diarrhoea, % (N)10.7 (36)10.1 (7)25.0 (9)28.6 (4)
IHD, % (N)13.4 (48)54.4 (37)10.5 (4)69.2 (9)
Asthma, % (N)6.1 (22)45.6 (31)2.6 (1)53.9 (7)
Hypertension, % (N)7.5 (27)38.2 (26)7.9 (3)53.9 (7)
Dementia, % (N)7.8 (28)20.6 (14)7.9 (3)23.1 (3)
Frailty, % (N)9.8 (35)35.3 (24)7.9 (3)46.2 (6)
ALD-CLD, % (N)0.3 (1)8.8 (6)0 (0)15.4 (2)
Malignancy, % (N)2.2 (8)19.1 (13)0 (0)46.2 (6)
PE, % (N)0 (0)7.4 (5)0 (0)7.7 (1)
Vitamin D (nmol/L)
 Mean (SD)51.8 (30.6)53.9 (26.9)51.9 (30.7)51.9 (18.6)
 Median (IQR)49 (26–71)55 (28–73)43 (29–72)54 (49–60)
 Range8–19510–1328–13214–86
Loge vitamin D
 Mean (SD)3.76 (0.64)3.83 (0.60)3.77 (0.65)3.87 (0.47)
 Median (IQR)3.89 (3.26–4.26)4.01 (3.31–4.29)3.76 (3.36–4.29)3.99 (3.80–4.11)
 Range2.08–5.272.30–4.882.08–4.882.64–4.45
Vitamin D <25 nmol/L23.6 (86)18.8 (13)21.1 (8)14.3 (2)
COVID-19 swab-positive10.4 (38)20.3 (14)
  • Frailty: Dalhousie Frailty (Rockwood) score of 4 or more classified as frail.

  • ALD, alcohol liver disease; CLD, chronic liver disease; COPD, chronic obstructive pulmonary disease; IHD, ischaemic heart disease; ILD, interstitial ung disease; PE, pulmonary embolism.